Professional Documents
Culture Documents
Contents - 2023 - Neurosurgery-Clinics-of-North-America 2
Contents - 2023 - Neurosurgery-Clinics-of-North-America 2
Contents - 2023 - Neurosurgery-Clinics-of-North-America 2
Contents
Preface: Advances in the Field of Chiari I Malformation and Integrating Them into Clinical
Practice xv
David D. Limbrick, Jr and Jeffrey R. Leonard
Socioeconomic and demographic factors affect the care of patients with Chiari I
malformations. This article describes the current cost of surgical treatment of Chiari
I malformations and highlights how careful patient selection, treatment selection,
postoperative protocols, and varying payment models may serve as cost-
reducing measures. In addition, the article highlights racial disparities resulting in de-
layed diagnosis and greater disease progression in non-white patients, as well as the
relative parity in the workup and treatment of Chiari I malformation based on insur-
ance status. These findings illustrate the need for greater access to neurosurgical
care and greater outreach to community physicians by the neurosurgical
community.
Individuals with Chiari malformation can present with symptoms of fatigue, light-
headedness, and syncope—the cardinal features of orthostatic intolerance. Similar
orthostatic symptoms can complicate the clinical course following Chiari decom-
pression. The presence of orthostatic intolerance in patients with Chiari malforma-
tion is not surprising given the location of the major circulatory control centers
and their pathways in the brainstem. This article reviews the normal physiologic
response to upright posture and the common forms of orthostatic intolerance
encountered in clinical practice. The authors describe the relationship between
orthostatic intolerance and Chiari malformation and provide suggestions regarding
the evaluation and management of these disorders.
Several studies have been performed to elucidate the genetic basis of Chiari I mal-
formation (CM1). The heritability of CM1 is clear from twin studies, familial clustering,
and the prevalence of CM1 among certain classes of Mendelian disorders, namely
connective tissue disorders, brain overgrowth disorders, disorders of CSF homeo-
stasis, certain tumors, disorders of skull development and vascular conditions. A
comprehensive understanding of the causes of CM1 will require large cohorts of pa-
tients for genetic studies and in-depth phenotyping of cases to better understand
the biological mechanisms underlying disease.
syndrome, and a wide range of skeletal dysplasias. Recent evidence suggests that
people with the HDCTs are at an increased risk of Chiari I malformation (CM1).
In this study, the authors summarize the current knowledge on epidemiology, demo-
graphics, risk factors, and prognostic factors that influence outcomes in patients
with adult Chiari malformation type I (CM-I) who underwent posterior fossa decom-
pression surgery with duraplasty. Furthermore, they describe the contribution of
their research group to the field of adult CM-I treatment, including the association
of increased body mass index with severity of CM-I and syringomyelia, relevant sur-
gical anatomy, and surgical technique of 270 microsurgical decompression of fora-
men magnum. The authors also report on common complications in the literature
and describe techniques for prevention of complications.
x Contents
Posterior Fossa Decompression with or Without Duraplasty for Chiari I Malformation 105
Alexander T. Yahanda and David D. Limbrick, Jr
Surgery is the treatment of choice for symptomatic patients with Chiari anomalies
Although the surgical treatment of Chiari anomalies in adults is a straightforward pro-
cedure, complications and less than satisfactory outcomes do occur. Understand-
ing these complications is important for correcting the problem as well as
preventing the recurrence of similar problems. In this article, the author review the
short-term and long-term complications associated with posterior fossa decom-
pression for Chiari malformation.
Craniovertebral junction (CVJ) abnormalities are associated with the Chiari malfor-
mation type I. These abnormalities may lead to ventral brainstem compression
which can be reduced with traction and posterior reduction using instrumentation.
In other cases, the irreducible CVJ pathology with persistent ventral brainstem
compression requires ventral decompression. In all cases, a posterior extradural
or extra-intradural decompression is required along with an occipitocervical fusion
to maintain the reduced and realigned CVJ or stabilize the CVJ after a ventral
decompression.
The term “complex Chiari malformation” (CCM) refers to a subset of clinical and
radiographic findings that describe a subpopulation of Chiari patients with cranio-
cervical kyphosis and secondary brainstem compression. These patients are at a
greater risk for unsuccessful surgical treatment with standard Chiari surgical decom-
pressive procedures and may require craniocervical fusion and/or odontoid resec-
tion. This article reviews concepts related to the diagnosis, management, and
treatment of CCM and discusses possible directions for future research.
CM-I-associated syringomyelia is a risk factor for scoliosis where a larger syrinx size
is more likely to be associated with scoliosis. Therefore, the effect of syrinx on scoli-
osis progression may be alleviated by PFD. There is no difference in the need for
fusion surgery between patients undergoing PFD with duraplasty vs. those undergo-
ing extradural decompression; however, PFD with duraplasty is associated with an
improvement in curve magnitude compared to extradural decompression alone.
Further study on the comparison of PFD techniques for this cohort of patients is
needed. PFD is a durable surgical option for patients with CM-I, syrinx, and scoliosis.
Early decompression of CM-I in younger patients and those with smaller curve
magnitude at presentation is recommended as there is a higher likelihood of halting
curve progression.
The purpose of this article was to consider, evaluate, and compare the clinical out-
comes measurement tools that are used to assess patients with Chiari I malforma-
tion. This article highlights the variety of general and disease-specific outcome
measures used in both the pediatric and adult Chiari I malformation patient popula-
tions. Although general measures can be associated with clinical outcomes and
quality of life, that association is not often found to be statistically significant, and
they do not often have the capabilities to assess and measure factors that directly
impact the Chiari patient population. However, limitations exist when considering
the disease-specific outcome measures, as these tools most often have not been
rigorously evaluated externally from the initial validation or have been externally vali-
dated but results cannot be replicated. Identifying an outcomes measurement tool
xii Contents
for both adults and patients will contribute to the clinical tools available to providers
for decision-making and management.